Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
- PMID: 35837110
- PMCID: PMC9274301
- DOI: 10.3389/fonc.2022.916983
Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
Abstract
[This corrects the article DOI: 10.3389/fonc.2022.827891.].
Keywords: ATP7A; chemoresistance; colorectal cancer; oxaliplatin; siRNA delivery.
Copyright © 2022 Zhou, Zhang, Wang, Huang and Yao.
Figures

Erratum for
-
Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer.Front Oncol. 2022 Feb 21;12:827891. doi: 10.3389/fonc.2022.827891. eCollection 2022. Front Oncol. 2022. PMID: 35265524 Free PMC article.
Similar articles
-
Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer.Front Oncol. 2022 Feb 21;12:827891. doi: 10.3389/fonc.2022.827891. eCollection 2022. Front Oncol. 2022. PMID: 35265524 Free PMC article.
-
Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer.Drug Deliv. 2021 Dec;28(1):920-929. doi: 10.1080/10717544.2021.1914777. Drug Deliv. 2021. PMID: 33974471 Free PMC article.
-
Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.Front Oncol. 2023 Mar 28;13:1147497. doi: 10.3389/fonc.2023.1147497. eCollection 2023. Front Oncol. 2023. PMID: 37056342 Free PMC article.
-
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy.Life Sci. 2022 Jun 1;298:120463. doi: 10.1016/j.lfs.2022.120463. Epub 2022 Mar 6. Life Sci. 2022. PMID: 35259354 Review.
-
Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancer.Biomed Pharmacother. 2020 Aug;128:110329. doi: 10.1016/j.biopha.2020.110329. Epub 2020 Jun 2. Biomed Pharmacother. 2020. PMID: 32502843 Review.
Cited by
-
Potential Application of Small Interfering RNA in Gastro-Intestinal Tumors.Pharmaceuticals (Basel). 2022 Oct 20;15(10):1295. doi: 10.3390/ph15101295. Pharmaceuticals (Basel). 2022. PMID: 36297407 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources